PMC:7283670 / 16860-18012 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T8497","span":{"begin":323,"end":328},"obj":"Body_part"},{"id":"T44276","span":{"begin":344,"end":349},"obj":"Body_part"},{"id":"T34261","span":{"begin":532,"end":540},"obj":"Body_part"}],"attributes":[{"id":"A47781","pred":"fma_id","subj":"T8497","obj":"http://purl.org/sig/ont/fma/fma63083"},{"id":"A26938","pred":"fma_id","subj":"T44276","obj":"http://purl.org/sig/ont/fma/fma50801"},{"id":"A39617","pred":"fma_id","subj":"T34261","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":"3.1 Sex\nSeveral studies have sought to compare the sex differences in the clinical findings of severe COVID‐19. In one study, scientists investigated 47 patients with COVID‐19, 28 (59.6%) of whom were men. Procalcitonin (PCT) level was reported to be higher in men than in women. The results also showed higher amounts of serum N‐terminal‐pro brain natriuretic peptide, as increased levels of the molecule were detected in men 57.1% than women 26.3%. Furthermore, 17.9% of male patients were reported test‐positive for influenza A antibody, whereas no such records were registered for female patients. During a 2‐week stay at the hospital, 17.9% of male, and 5.3% of female patients deteriorated, and hence were reassigned to the critical‐type group. There was no mortality reports among women, whereas 3.6% of male patients had deceased due to COVID‐19 complications. A total of 21.1% and 3.6% of female and male patients successfully recovered, and were discharged from the hospital. Based on the current evidence, men are more likely to develop complications, and experience worse in‐hospital outcomes compared with women (Li, Zhang, et al., 2020)."}

    LitCovid-PD-UBERON

    {"project":"LitCovid-PD-UBERON","denotations":[{"id":"T33","span":{"begin":323,"end":328},"obj":"Body_part"},{"id":"T34","span":{"begin":344,"end":349},"obj":"Body_part"}],"attributes":[{"id":"A33","pred":"uberon_id","subj":"T33","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"},{"id":"A34","pred":"uberon_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/UBERON_0000955"}],"text":"3.1 Sex\nSeveral studies have sought to compare the sex differences in the clinical findings of severe COVID‐19. In one study, scientists investigated 47 patients with COVID‐19, 28 (59.6%) of whom were men. Procalcitonin (PCT) level was reported to be higher in men than in women. The results also showed higher amounts of serum N‐terminal‐pro brain natriuretic peptide, as increased levels of the molecule were detected in men 57.1% than women 26.3%. Furthermore, 17.9% of male patients were reported test‐positive for influenza A antibody, whereas no such records were registered for female patients. During a 2‐week stay at the hospital, 17.9% of male, and 5.3% of female patients deteriorated, and hence were reassigned to the critical‐type group. There was no mortality reports among women, whereas 3.6% of male patients had deceased due to COVID‐19 complications. A total of 21.1% and 3.6% of female and male patients successfully recovered, and were discharged from the hospital. Based on the current evidence, men are more likely to develop complications, and experience worse in‐hospital outcomes compared with women (Li, Zhang, et al., 2020)."}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T96","span":{"begin":103,"end":111},"obj":"Disease"},{"id":"T97","span":{"begin":168,"end":176},"obj":"Disease"},{"id":"T98","span":{"begin":222,"end":225},"obj":"Disease"},{"id":"T100","span":{"begin":520,"end":529},"obj":"Disease"},{"id":"T101","span":{"begin":846,"end":854},"obj":"Disease"}],"attributes":[{"id":"A96","pred":"mondo_id","subj":"T96","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A97","pred":"mondo_id","subj":"T97","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A98","pred":"mondo_id","subj":"T98","obj":"http://purl.obolibrary.org/obo/MONDO_0008296"},{"id":"A99","pred":"mondo_id","subj":"T98","obj":"http://purl.obolibrary.org/obo/MONDO_0015104"},{"id":"A100","pred":"mondo_id","subj":"T100","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A101","pred":"mondo_id","subj":"T101","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"3.1 Sex\nSeveral studies have sought to compare the sex differences in the clinical findings of severe COVID‐19. In one study, scientists investigated 47 patients with COVID‐19, 28 (59.6%) of whom were men. Procalcitonin (PCT) level was reported to be higher in men than in women. The results also showed higher amounts of serum N‐terminal‐pro brain natriuretic peptide, as increased levels of the molecule were detected in men 57.1% than women 26.3%. Furthermore, 17.9% of male patients were reported test‐positive for influenza A antibody, whereas no such records were registered for female patients. During a 2‐week stay at the hospital, 17.9% of male, and 5.3% of female patients deteriorated, and hence were reassigned to the critical‐type group. There was no mortality reports among women, whereas 3.6% of male patients had deceased due to COVID‐19 complications. A total of 21.1% and 3.6% of female and male patients successfully recovered, and were discharged from the hospital. Based on the current evidence, men are more likely to develop complications, and experience worse in‐hospital outcomes compared with women (Li, Zhang, et al., 2020)."}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T23649","span":{"begin":344,"end":349},"obj":"http://purl.obolibrary.org/obo/UBERON_0000955"},{"id":"T78531","span":{"begin":344,"end":349},"obj":"http://www.ebi.ac.uk/efo/EFO_0000302"},{"id":"T65904","span":{"begin":362,"end":369},"obj":"http://purl.obolibrary.org/obo/PR_000018263"},{"id":"T51594","span":{"begin":474,"end":478},"obj":"http://purl.obolibrary.org/obo/UBERON_0003101"},{"id":"T20327","span":{"begin":474,"end":478},"obj":"http://www.ebi.ac.uk/efo/EFO_0000970"},{"id":"T84110","span":{"begin":502,"end":506},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T45479","span":{"begin":530,"end":531},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T39142","span":{"begin":586,"end":592},"obj":"http://purl.obolibrary.org/obo/UBERON_0003100"},{"id":"T58341","span":{"begin":610,"end":613},"obj":"http://purl.obolibrary.org/obo/CLO_0001562"},{"id":"T30040","span":{"begin":610,"end":613},"obj":"http://purl.obolibrary.org/obo/CLO_0001563"},{"id":"T97903","span":{"begin":650,"end":654},"obj":"http://purl.obolibrary.org/obo/UBERON_0003101"},{"id":"T17459","span":{"begin":650,"end":654},"obj":"http://www.ebi.ac.uk/efo/EFO_0000970"},{"id":"T48920","span":{"begin":668,"end":674},"obj":"http://purl.obolibrary.org/obo/UBERON_0003100"},{"id":"T57801","span":{"begin":812,"end":816},"obj":"http://purl.obolibrary.org/obo/UBERON_0003101"},{"id":"T95937","span":{"begin":812,"end":816},"obj":"http://www.ebi.ac.uk/efo/EFO_0000970"},{"id":"T40101","span":{"begin":870,"end":871},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T38911","span":{"begin":899,"end":905},"obj":"http://purl.obolibrary.org/obo/UBERON_0003100"},{"id":"T32044","span":{"begin":910,"end":914},"obj":"http://purl.obolibrary.org/obo/UBERON_0003101"},{"id":"T75823","span":{"begin":910,"end":914},"obj":"http://www.ebi.ac.uk/efo/EFO_0000970"},{"id":"T65577","span":{"begin":1127,"end":1129},"obj":"http://purl.obolibrary.org/obo/CLO_0001022"},{"id":"T318","span":{"begin":1127,"end":1129},"obj":"http://purl.obolibrary.org/obo/CLO_0007314"}],"text":"3.1 Sex\nSeveral studies have sought to compare the sex differences in the clinical findings of severe COVID‐19. In one study, scientists investigated 47 patients with COVID‐19, 28 (59.6%) of whom were men. Procalcitonin (PCT) level was reported to be higher in men than in women. The results also showed higher amounts of serum N‐terminal‐pro brain natriuretic peptide, as increased levels of the molecule were detected in men 57.1% than women 26.3%. Furthermore, 17.9% of male patients were reported test‐positive for influenza A antibody, whereas no such records were registered for female patients. During a 2‐week stay at the hospital, 17.9% of male, and 5.3% of female patients deteriorated, and hence were reassigned to the critical‐type group. There was no mortality reports among women, whereas 3.6% of male patients had deceased due to COVID‐19 complications. A total of 21.1% and 3.6% of female and male patients successfully recovered, and were discharged from the hospital. Based on the current evidence, men are more likely to develop complications, and experience worse in‐hospital outcomes compared with women (Li, Zhang, et al., 2020)."}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T39","span":{"begin":344,"end":369},"obj":"Chemical"},{"id":"T40","span":{"begin":362,"end":369},"obj":"Chemical"},{"id":"T41","span":{"begin":398,"end":406},"obj":"Chemical"},{"id":"T42","span":{"begin":474,"end":478},"obj":"Chemical"},{"id":"T43","span":{"begin":650,"end":654},"obj":"Chemical"},{"id":"T44","span":{"begin":745,"end":750},"obj":"Chemical"},{"id":"T45","span":{"begin":812,"end":816},"obj":"Chemical"},{"id":"T46","span":{"begin":910,"end":914},"obj":"Chemical"},{"id":"T47","span":{"begin":1127,"end":1129},"obj":"Chemical"}],"attributes":[{"id":"A39","pred":"chebi_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/CHEBI_80234"},{"id":"A40","pred":"chebi_id","subj":"T40","obj":"http://purl.obolibrary.org/obo/CHEBI_16670"},{"id":"A41","pred":"chebi_id","subj":"T41","obj":"http://purl.obolibrary.org/obo/CHEBI_25367"},{"id":"A42","pred":"chebi_id","subj":"T42","obj":"http://purl.obolibrary.org/obo/CHEBI_30780"},{"id":"A43","pred":"chebi_id","subj":"T43","obj":"http://purl.obolibrary.org/obo/CHEBI_30780"},{"id":"A44","pred":"chebi_id","subj":"T44","obj":"http://purl.obolibrary.org/obo/CHEBI_24433"},{"id":"A45","pred":"chebi_id","subj":"T45","obj":"http://purl.obolibrary.org/obo/CHEBI_30780"},{"id":"A46","pred":"chebi_id","subj":"T46","obj":"http://purl.obolibrary.org/obo/CHEBI_30780"},{"id":"A47","pred":"chebi_id","subj":"T47","obj":"http://purl.obolibrary.org/obo/CHEBI_30145"}],"text":"3.1 Sex\nSeveral studies have sought to compare the sex differences in the clinical findings of severe COVID‐19. In one study, scientists investigated 47 patients with COVID‐19, 28 (59.6%) of whom were men. Procalcitonin (PCT) level was reported to be higher in men than in women. The results also showed higher amounts of serum N‐terminal‐pro brain natriuretic peptide, as increased levels of the molecule were detected in men 57.1% than women 26.3%. Furthermore, 17.9% of male patients were reported test‐positive for influenza A antibody, whereas no such records were registered for female patients. During a 2‐week stay at the hospital, 17.9% of male, and 5.3% of female patients deteriorated, and hence were reassigned to the critical‐type group. There was no mortality reports among women, whereas 3.6% of male patients had deceased due to COVID‐19 complications. A total of 21.1% and 3.6% of female and male patients successfully recovered, and were discharged from the hospital. Based on the current evidence, men are more likely to develop complications, and experience worse in‐hospital outcomes compared with women (Li, Zhang, et al., 2020)."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T130","span":{"begin":0,"end":8},"obj":"Sentence"},{"id":"T131","span":{"begin":9,"end":112},"obj":"Sentence"},{"id":"T132","span":{"begin":113,"end":206},"obj":"Sentence"},{"id":"T133","span":{"begin":207,"end":280},"obj":"Sentence"},{"id":"T134","span":{"begin":281,"end":451},"obj":"Sentence"},{"id":"T135","span":{"begin":452,"end":602},"obj":"Sentence"},{"id":"T136","span":{"begin":603,"end":751},"obj":"Sentence"},{"id":"T137","span":{"begin":752,"end":869},"obj":"Sentence"},{"id":"T138","span":{"begin":870,"end":986},"obj":"Sentence"},{"id":"T139","span":{"begin":987,"end":1152},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"3.1 Sex\nSeveral studies have sought to compare the sex differences in the clinical findings of severe COVID‐19. In one study, scientists investigated 47 patients with COVID‐19, 28 (59.6%) of whom were men. Procalcitonin (PCT) level was reported to be higher in men than in women. The results also showed higher amounts of serum N‐terminal‐pro brain natriuretic peptide, as increased levels of the molecule were detected in men 57.1% than women 26.3%. Furthermore, 17.9% of male patients were reported test‐positive for influenza A antibody, whereas no such records were registered for female patients. During a 2‐week stay at the hospital, 17.9% of male, and 5.3% of female patients deteriorated, and hence were reassigned to the critical‐type group. There was no mortality reports among women, whereas 3.6% of male patients had deceased due to COVID‐19 complications. A total of 21.1% and 3.6% of female and male patients successfully recovered, and were discharged from the hospital. Based on the current evidence, men are more likely to develop complications, and experience worse in‐hospital outcomes compared with women (Li, Zhang, et al., 2020)."}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"393","span":{"begin":154,"end":162},"obj":"Species"},{"id":"394","span":{"begin":202,"end":205},"obj":"Species"},{"id":"395","span":{"begin":262,"end":265},"obj":"Species"},{"id":"396","span":{"begin":274,"end":279},"obj":"Species"},{"id":"397","span":{"begin":424,"end":427},"obj":"Species"},{"id":"398","span":{"begin":439,"end":444},"obj":"Species"},{"id":"399","span":{"begin":479,"end":487},"obj":"Species"},{"id":"400","span":{"begin":593,"end":601},"obj":"Species"},{"id":"401","span":{"begin":675,"end":683},"obj":"Species"},{"id":"402","span":{"begin":789,"end":794},"obj":"Species"},{"id":"403","span":{"begin":817,"end":825},"obj":"Species"},{"id":"404","span":{"begin":915,"end":923},"obj":"Species"},{"id":"405","span":{"begin":1018,"end":1021},"obj":"Species"},{"id":"406","span":{"begin":1120,"end":1125},"obj":"Species"},{"id":"407","span":{"begin":520,"end":529},"obj":"Species"},{"id":"408","span":{"begin":103,"end":111},"obj":"Disease"},{"id":"409","span":{"begin":168,"end":176},"obj":"Disease"},{"id":"410","span":{"begin":765,"end":774},"obj":"Disease"},{"id":"411","span":{"begin":846,"end":854},"obj":"Disease"}],"attributes":[{"id":"A393","pred":"tao:has_database_id","subj":"393","obj":"Tax:9606"},{"id":"A394","pred":"tao:has_database_id","subj":"394","obj":"Tax:9606"},{"id":"A395","pred":"tao:has_database_id","subj":"395","obj":"Tax:9606"},{"id":"A396","pred":"tao:has_database_id","subj":"396","obj":"Tax:9606"},{"id":"A397","pred":"tao:has_database_id","subj":"397","obj":"Tax:9606"},{"id":"A398","pred":"tao:has_database_id","subj":"398","obj":"Tax:9606"},{"id":"A399","pred":"tao:has_database_id","subj":"399","obj":"Tax:9606"},{"id":"A400","pred":"tao:has_database_id","subj":"400","obj":"Tax:9606"},{"id":"A401","pred":"tao:has_database_id","subj":"401","obj":"Tax:9606"},{"id":"A402","pred":"tao:has_database_id","subj":"402","obj":"Tax:9606"},{"id":"A403","pred":"tao:has_database_id","subj":"403","obj":"Tax:9606"},{"id":"A404","pred":"tao:has_database_id","subj":"404","obj":"Tax:9606"},{"id":"A405","pred":"tao:has_database_id","subj":"405","obj":"Tax:9606"},{"id":"A406","pred":"tao:has_database_id","subj":"406","obj":"Tax:9606"},{"id":"A407","pred":"tao:has_database_id","subj":"407","obj":"Tax:11309"},{"id":"A408","pred":"tao:has_database_id","subj":"408","obj":"MESH:C000657245"},{"id":"A409","pred":"tao:has_database_id","subj":"409","obj":"MESH:C000657245"},{"id":"A410","pred":"tao:has_database_id","subj":"410","obj":"MESH:D003643"},{"id":"A411","pred":"tao:has_database_id","subj":"411","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"3.1 Sex\nSeveral studies have sought to compare the sex differences in the clinical findings of severe COVID‐19. In one study, scientists investigated 47 patients with COVID‐19, 28 (59.6%) of whom were men. Procalcitonin (PCT) level was reported to be higher in men than in women. The results also showed higher amounts of serum N‐terminal‐pro brain natriuretic peptide, as increased levels of the molecule were detected in men 57.1% than women 26.3%. Furthermore, 17.9% of male patients were reported test‐positive for influenza A antibody, whereas no such records were registered for female patients. During a 2‐week stay at the hospital, 17.9% of male, and 5.3% of female patients deteriorated, and hence were reassigned to the critical‐type group. There was no mortality reports among women, whereas 3.6% of male patients had deceased due to COVID‐19 complications. A total of 21.1% and 3.6% of female and male patients successfully recovered, and were discharged from the hospital. Based on the current evidence, men are more likely to develop complications, and experience worse in‐hospital outcomes compared with women (Li, Zhang, et al., 2020)."}